MARKSANS
Marksans Pharma Limited
Healthcare
Share price
₹291
Market cap
₹13,183 Cr
1Y return
▲ 51%
A pharmaceutical formulation company engaged in the development and manufacture of a diverse range of drugs across multiple therapeutic areas for domestic and international markets. Marksans Pharma produces generic medications and branded formulations with a focus on quality and regulatory compliance. The company operates modern manufacturing facilities designed to meet stringent pharmaceutical production standards and global quality requirements.
Investors holding Marksans Pharma Limited
1.66%
Recent moves 4
Kotak Mutual FundExited
Kotak Mutual Fund's name has dropped from Marksans Pharma Limited's latest shareholder list. After previously holding a 1.14 percent stake, Kotak Mutual Fund has either fully exited the company or trimmed its position below the 1 percent disclosure threshold.
Read more
UTI Mutual FundDecreased
UTI Mutual Fund trimmed its stake in Marksans Pharma Limited from 2.11% to 1.66%, selling 20,26,054 shares.
Read more
Kotak Mutual FundIncreased
Kotak Mutual Fund increased its stake in Marksans Pharma from 1.13% to 1.14%, buying 20,101 shares.
Read more
UTI Mutual FundDecreased
UTI Mutual Fund decreased its stake in Marksans Pharma from 2.49% to 2.11%, selling 17,45,067 shares.
Read more
Track the whales in Marksans Pharma Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1